| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |